What are the open and close dates of the Accretion Pharmaceuticals IPO ?

Accretion Pharmaceuticals IPO will be open between 2025-05-14 and 2025-05-16.

What is the allotment date for the Accretion Pharmaceuticals IPO ?

Accretion Pharmaceuticals IPO allotment date is 2025-05-20. For Accretion Pharmaceuticals IPO allotment status check, you can visit the website of the registrar of the IPO.

Who is the registrar of Accretion Pharmaceuticals IPO ?

For Accretion Pharmaceuticals IPO, the IPO registrar is Kfin Technologies Limited. You can check Accretion Pharmaceuticals IPO allotment status on the website of the registrar.

Where is the Accretion Pharmaceuticals IPO getting listed?

The shares are proposed to be listed on the BSE and NSE.

When will Accretion Pharmaceuticals IPO shares be credited to your demat account?

The Accretion Pharmaceuticals IPO shares will typically be credited to your demat account one working day before the IPO's listing date, provided your application is successfully allotted.

What is the lot size and minimum order quantity of the Accretion Pharmaceuticals IPO ?

The Accretion Pharmaceuticals IPO lot size is 1200 and minimum order quantity is 1200.

What is the price band for the Accretion Pharmaceuticals IPO ?

Accretion Pharmaceuticals IPO has set the price band for its IPO at 101 per equity share with a face value of 10.

5.51x

subscribed

Accretion Pharmaceuticals IPO

Pharmaceuticals & Drugs

listed

₹1.15LMin. investment

Pre-apply
12 May
Bid start
14 May
Bid end
16 May
Allotment
19 May
Release of funds
20 May
Demat transfer
20 May
Listing
21 May

Accretion Pharmaceuticals Limited IPO Details

Issue size

₹29Cr

IPO type

SME

Market Cap

₹112.27CrLower than sector avg

Price range

₹96.00 – ₹101

Listing ExchangeNSE

RevenueApr 2023 - Mar 2024

₹33.66CrLower than sector avg

Lot size

1200 shares

Red Herring Prospectus

Read

Growth rate3Y CAGR

22.88%

SectorPharmaceuticals & Drugs

Price range₹96.00 – ₹101

IPO type

SME

Lot size1200 shares

Issue size₹29Cr

Red Herring Prospectus

Read

Market Cap

₹112.27CrLower than sector avg

RevenueApr 2023 - Mar 2024

₹33.66CrLower than sector avg

Growth rate3Y CAGR

22.88%

Checklist

Quality analysis

Revenue growth

Company valuation

Earnings expansion

Risk analysis

Debt to Equity ratio

Promoter holdings

Shares pledged

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Compare

Companies in this sector

Sun Pharmaceutical Industries Ltd

Divi's Laboratories Ltd

Torrent Pharmaceuticals Ltd

Revenue

Higher revenue means strong sales and good market demand

This IPO

₹33.66Cr

This sector

₹1,331.47Cr

Compare with companies

PAT

Higher PAT means strong profitability and efficient cost management

This IPO

₹3.87Cr

This sector

₹193.4Cr

Compare with companies

Market cap

Higher market cap means strong confidence but may suggest overvaluation

This IPO

₹112.27Cr

This sector

₹10,914.84Cr

Compare with companies

P/E ratio

Lower ratio usually means stock is undervalued

This IPO

29.01

This sector

60.87

Compare with companies

D/E ratio

Lower ratio usually means fewer liabilities

This IPO

1.02

This sector

0.43

Compare with companies

Objectives

Working capital requirements

49.30%

General corporate purposes

22.71%

Capex for upgradation

15.63%

Capex to purchase new equipment

9.04%

Repayment or prepayment of borrowings

3.32%

About Accretion Pharmaceuticals Limited

Incorporated in 2012, Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing tablets, capsules, oral liquids, and external preparations (Ointment, Cream, Gel, Lotion & more). The company operates on a B2B model, serving domestic and export clients through direct sales and contract manufacturing. It earned 72.9% of its total revenue from the top 10 clients in FY24. The company has a manufacturing facility in Sanand, which has advanced machinery and efficient processes tailored to customer demand.

Accretion Pharmaceuticals IPO Subscription Status

Date	QIB	NII	Retail	Total
14-May-25	0.0 times (X)	0.0 times (X)	1.82 times (X)	0.86 times (X)
15-May-25	0.75X	0.0X	3.98X	1.92X
16-May-25	12.14X	0.0X	10.26X	5.51X

Latest News on Accretion Pharmaceuticals IPO

Gujarat-based Accretion Pharmaceuticals has decided to hit the Dalal Street with its maiden public issue on May 14. The last day to subscribe to the said issue will be May 16.The company aims to mop up Rs 29.75 crore via IPO of 29.46 lakh shares at a price of Rs 101 per share. Proceeds will fund equipment purchases, facility upgrades, debt repayment, and working capital.

Frequently asked questions

How to invest in the Accretion Pharmaceuticals IPO ?

Investors can apply for the Accretion Pharmaceuticals IPO through their Demat account via the stock exchange or through their broker.

What is the issue size of Accretion Pharmaceuticals IPO ?

The issue size of the Accretion Pharmaceuticals IPO is 29 Cr.

What is 'pre-apply' for Accretion Pharmaceuticals IPO ?

Pre-applying for an IPO allows you to submit your application before the official subscription period begins.

Which exchanges will Accretion Pharmaceuticals IPO shares list on?

The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.